These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29397316)

  • 21. [Clinical study on effect of Erzhi Tiangui Granule in improving the quality of oocytes and leukemia inhibitory factor in follicular fluid of women undergoing in vitro fertilization and embryo transfer].
    Lian F; Teng YL; Zhang JW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Nov; 27(11):976-9. PubMed ID: 18173139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization.
    Niu Z; Lin N; Gu R; Sun Y; Feng Y
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2269-76. PubMed ID: 24694334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High androgen level during controlled ovarian stimulation cycle impairs endometrial receptivity in PCOS patients.
    Wei SY; Zhang JL; Guan HQ; Cai JJ; Jiang XF; Wang H; Wu DD; Lin XH
    Sci Rep; 2024 Oct; 14(1):23100. PubMed ID: 39367050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic profile of follicular fluid from patients with polycystic ovary syndrome (PCOS) submitted to in vitro fertilization (IVF) compared to oocyte donors.
    Domingues TS; Bonetti TC; Pimenta DC; Mariano DOC; Barros B; Aquino AP; Motta ELA
    JBRA Assist Reprod; 2019 Oct; 23(4):367-391. PubMed ID: 31173497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles.
    Amato G; Conte M; Mazziotti G; Lalli E; Vitolo G; Tucker AT; Bellastella A; Carella C; Izzo A
    Obstet Gynecol; 2003 Jun; 101(6):1177-82. PubMed ID: 12798522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
    Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
    Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome.
    Wu R; Fujii S; Ryan NK; Van der Hoek KH; Jasper MJ; Sini I; Robertson SA; Robker RL; Norman RJ
    Hum Reprod; 2007 Feb; 22(2):527-35. PubMed ID: 16997933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study.
    Wang Y; Huang R; Li X; Zhu Q; Liao Y; Tao T; Kang X; Liu W; Li S; Sun Y
    Gynecol Endocrinol; 2019 Dec; 35(12):1072-1077. PubMed ID: 31155988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of sex hormone-binding globulin polymorphisms on the outcome of in vitro fertilization-embryo transfer for polycystic ovary syndrome patients: A case-control study.
    Liu Y; Zhao XX; Hu XJ; Yang F; Lin P; Cui SC; Zhao W; Cao XY; Wang YS
    J Cell Biochem; 2019 Mar; 120(3):4675-4686. PubMed ID: 30520140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome.
    Wang B; Hao M; Yang Q; Li J; Guo Y
    J Assist Reprod Genet; 2016 Jul; 33(7):959-65. PubMed ID: 27011370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome.
    Timur H; Yimaz N; Kahyaoglu I; Inal HA; Erkaya S
    J Assist Reprod Genet; 2015 Nov; 32(11):1637-42. PubMed ID: 26463878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular fluid norepinephrine and dopamine concentrations are higher in polycystic ovary syndrome.
    Musalı N; Özmen B; Şükür YE; Ergüder Bİ; Atabekoğlu CS; Sönmezer M; Berker B; Aytaç R
    Gynecol Endocrinol; 2016 Jun; 32(6):460-3. PubMed ID: 26754116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome.
    Inal ZO; Inal HA; Erdem S
    Mol Biol Rep; 2018 Dec; 45(6):2037-2044. PubMed ID: 30194556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome.
    Cordeiro FB; Cataldi TR; de Souza BZ; Rochetti RC; Fraietta R; Labate CA; Lo Turco EG
    Metabolomics; 2018 Mar; 14(4):51. PubMed ID: 30830356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
    Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
    Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated signal transducer and activator of transcription 3 expression in fertile patients with polycystic ovarian syndrome.
    Li MG; Ding GL; Chen XJ; Lu XP; Dong LJ; Dong MY; Yang XF; Lu XE; Huang HF
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4771-6. PubMed ID: 17895321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries].
    Wang QL; Song J; Chen SL; Luo C; Chen X; Li M; Ni YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):962-5. PubMed ID: 19460721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follicular-fluid anti-Mullerian hormone concentrations are predictive of assisted reproduction outcome in PCOS patients.
    Pabuccu R; Kaya C; Cağlar GS; Oztas E; Satiroglu H
    Reprod Biomed Online; 2009 Nov; 19(5):631-7. PubMed ID: 20021712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
    Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
    Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered expression of leukemia inhibitory factor (LIF), LIFR, gp130, and IL11 in the embryo implantation site of rat model with prenatal androgen-induced polycystic ovary syndrome.
    Javidan M; Changaei M; Ramezani Tehrani F; Mosaffa N; Noroozzadeh M; Hosseinzadeh R; Rajaei S
    Biochem Biophys Res Commun; 2022 May; 605():24-30. PubMed ID: 35306361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.